World-leading cancer diagnostics for everyone

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardised and AI-supported workflow to optimise quality and response times, initially within prostate.

World-leading
cancer diagnostics
for everyone

Meet the future of pathology

How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?

Welcome to our booth at Urologidagarna in Malmö, October 5–7. Let’s talk about how you can get visual and intuitive pathology reports within 5 days with high and consistent quality, created by world-leading AI in collaboration with experienced uropathologists.

Your patient, our priority

Urologidagarna i Malmö, booth #43
Malmö Live
October 5–7, 2022

CUSTOMER CASE | Capio Urosurgical Centre

“We had issues with long lead times for receiving results to our prostate biopsies. Inify delivers a solution where we get results within 5 working days. That was the main reason we started sending our samples to them”.

Martin Bergman

Consultant Urologist, CEO and founder
Capio Urosurgical Centre

One out of seven will be diagnosed with prostate cancer

Handling of prostate biopsies makes up an increasing amount of workload for today’s pathology labs. Here, powerful decision support tools – such as Inify Prostate – have the potential to save valuable time for the pathologist, while ensuring a more objective, consistent and accurate evaluation of the biopsies.

One out of seven will be diagnosed with prostate cancer

For more panel discussions, please visit our YouTube channel

PANEL TALK

Over 1,000 patients diagnosed: Panel talk Q2 report 2024

Inify reports sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients. More details about the laboratory operations and its success factors are discussed in a panel talk led by Ole Eikeland with Inify’s CEO Fredrik Palm and Laboratory Director Emelie Edvigsson.

CUSTOMER CASE | Urologifocus

Saved time and improved workflow

“The main difference for us since we started working with Inify is the time we save. Previously, we often had to call the pathology department to ask about missing test results and contact patients to reschedule due to delays. Now, we don’t have to deal with that at all.”

Elin Weilow,
Specalist nurse
Urologifocus

Click here to read more about what our customers think

PANEL TALK

Strong growth and 80% market share in Stockholm: Panel talk Q4 report 2024

Inify Laboratories is seeing significant growth, with a 60% sales increase in Q4 2024 compared to the previous quarter. By year-end, the company held 80% of the prostate diagnostics market in Stockholm and signed its first agreement with a regional healthcare provider. Inify is also making rapid progress with its expansion into the UK. Listen to the panel talk led by Ole Eikeland with Inify´s CEO Fredrik Palm.

For more panel discussions, please visit our YouTube channel

World-leading cancer diagnostics for everyone

World-leading
cancer diagnostics
for everyone

Services for
urology

Services for
gastroenterlogy

Services for
pathology

How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?

Your patient, our priority

Learn more about Inify Laboratories